Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke

NCT05719688 is registered in ClinicalTrials.gov with Suzhou Hengruihongyuan Medical Technology Co. LTD as lead sponsor.

NCT NCT05719688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05719688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke
Lead sponsor
Suzhou Hengruihongyuan Medical Technology Co. LTD
Phase
Not applicable
Overall status
Completed
Start date
December 16, 2022
Completion date
May 24, 2024
Enrollment
202 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke